SR 4835

CAS : 2387704-62-1

Ref. 3D-BS180614

Informations sur le produit

• Nom: SR 4835

Description

SR 4835 is a cytostatic drug that inhibits the transcriptional regulation of cancer cells. It has been shown to have clinical efficacy in prostate cancer, which is resistant to androgen deprivation therapy. SR 4835 also activates the response pathway by inhibiting the production of proteins that are essential for tumor growth. The mouse tumor model studies showed an antitumor response when SR 4835 was administered intraperitoneally, with a significant decrease in body weight. This drug also has prognostic value, as it predicts a better outcome after radical prostatectomy in patients with prostate cancer. SR 4835 is effective in the treatment of human protein-related cancers such as thz531 and repair mechanism.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 499.36 g/mol
• Formule: C₂₁H₂₀Cl₂N₁₀O
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder